Drug Safety / Springer
Citation Profile [Updated: 2025-01-21 17:37:07]
5 Years H Index
6
Impact Factor (IF)
0.03
5 Years IF
0.02
Data available in this
report
[Raw
data] [50 most cited papers]
[50 most relevant papers]
[cites used to compute IF]
[Recent
citations ][Frequent citing
series ] [more data in
EconPapers]
[
trace new citations] [Missing
citations? Add them now]
[Incorrect content? Let us
know]
Main indicators
Raw Data
| IF | AIF | CIF | IF5 | DOC | CDO | CIT | NCI | CCU | D2Y | C2Y | D5Y | C5Y | SC | %SC | CiY | II | AII | |
| 2012 | 0 | 0.52 | 0 | 0 | 7 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0.22 | |||||
| 2014 | 0 | 0.55 | 0 | 0 | 8 | 15 | 11 | 0 | 7 | 7 | 0 | 0 | 0.23 | |||||
| 2015 | 0 | 0.55 | 0 | 0 | 1 | 16 | 0 | 0 | 8 | 15 | 0 | 0 | 0.23 | |||||
| 2016 | 0.22 | 0.52 | 0.11 | 0.13 | 98 | 114 | 83 | 12 | 12 | 9 | 2 | 16 | 2 | 11 | 91.7 | 10 | 0.1 | 0.21 |
| 2017 | 0.15 | 0.54 | 0.15 | 0.16 | 119 | 233 | 84 | 34 | 46 | 99 | 15 | 114 | 18 | 30 | 88.2 | 11 | 0.09 | 0.22 |
| 2018 | 0.14 | 0.55 | 0.16 | 0.14 | 134 | 367 | 80 | 60 | 106 | 217 | 30 | 226 | 31 | 52 | 86.7 | 22 | 0.16 | 0.23 |
| 2019 | 0.09 | 0.56 | 0.16 | 0.08 | 131 | 498 | 58 | 78 | 184 | 253 | 24 | 360 | 28 | 68 | 87.2 | 33 | 0.25 | 0.23 |
| 2020 | 0.11 | 0.67 | 0.13 | 0.1 | 130 | 628 | 39 | 79 | 263 | 265 | 30 | 483 | 48 | 51 | 64.6 | 10 | 0.08 | 0.32 |
| 2021 | 0.08 | 0.79 | 0.11 | 0.07 | 124 | 752 | 32 | 79 | 342 | 261 | 22 | 612 | 45 | 49 | 62 | 10 | 0.08 | 0.29 |
| 2022 | 0.08 | 0.83 | 0.11 | 0.07 | 118 | 870 | 14 | 92 | 434 | 254 | 21 | 638 | 42 | 50 | 54.3 | 4 | 0.03 | 0.25 |
| 2023 | 0.06 | 0.82 | 0.05 | 0.04 | 85 | 955 | 9 | 43 | 477 | 242 | 15 | 637 | 25 | 19 | 44.2 | 5 | 0.06 | 0.23 |
| 2024 | 0.03 | 0.02 | 0.02 | 55 | 1010 | 0 | 24 | 501 | 203 | 6 | 588 | 14 | 11 | 45.8 | 0 |
| IF: | Two years Impact Factor: C2Y / D2Y |
| AIF: | Average Impact Factor for all series in RePEc in year y |
| CIF: | Cumulative impact factor |
| IF5: | Five years Impact Factor: C5Y / D5Y |
| DOC: | Number of documents published in year y |
| CDO: | Cumulative number of documents published until year y |
| CIT: | Number of citations to papers published in year y |
| NCI: | Number of citations in year y |
| CCU: | Cumulative number of citations to papers published until year y |
| D2Y: | Number of articles published in y-1 plus y-2 |
| C2Y: | Cites in y to articles published in y-1 plus y-2 |
| D5Y: | Number of articles published in y-1 until y-5 |
| C5Y: | Cites in y to articles published in y-1 until y-5 |
| SC: | selft citations in y to articles published in y-1 plus y-2 |
| %SC: | Percentage of selft citations in y to articles published in y-1 plus y-2 |
| CiY: | Cites in year y to documents published in year y |
| II: | Immediacy Index: CiY / Documents. |
| AII: | Average Immediacy Index for series in RePEc in year y |
50 most cited documents in this series
| # | Year | Title | Cited |
|---|---|---|---|
| 1 | 2017 | Natural Language Processing for EHR-Based Pharmacovigilance: A Structured Review. (2017). Starren, Justin ; Carson, Matthew B ; Jonnalagadda, Siddhartha R ; Berendsen, Mark A ; Zeng, Zexian ; Herr, Timothy M ; Thompson, William K ; Luo, Yuan. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:11:d:10.1007_s40264-017-0558-6. Full description at Econpapers || Download paper | 8 |
| 2 | 2017 | Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety Alerts. (2017). Brownstein, John S ; Freifeld, Clark C ; Le, Hoa ; Rodriguez, Harold W ; Proestel, Scott ; Pamer, Carol ; Bouri, Khaled ; Pierce, Carrie E ; Dasgupta, Nabarun ; Edwards, Ralph I ; Walderhaug, Mark. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:4:d:10.1007_s40264-016-0491-0. Full description at Econpapers || Download paper | 7 |
| 3 | 2014 | Text Mining for Adverse Drug Events: the Promise, Challenges, and State of the Art. (2014). Tamang, Suzanne ; Finlayson, Sam ; Harpaz, Rave ; LePendu, Paea ; Shah, Nigam ; Jung, Kenneth ; Odgers, David ; Callahan, Alison ; Low, Yen . In: Drug Safety. RePEc:spr:drugsa:v:37:y:2014:i:10:p:777-790. Full description at Econpapers || Download paper | 7 |
| 4 | 2018 | Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre. (2018). Hunsel, Florence ; Star, Kristina ; Zekarias, Alem ; Grundmark, Birgitta ; Harmark, Linda ; Taavola, Henric ; Chandler, Rebecca E ; Watson, Sarah. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:2:d:10.1007_s40264-017-0594-2. Full description at Econpapers || Download paper | 7 |
| 5 | 2016 | Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?. (2016). Leufkens, Hubert ; Kant, Agnes ; Raine, June ; Harmark, Linda ; Moretti, Ugo ; Sarinic, Viola Macolic ; Edwards, Ralph I. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:10:d:10.1007_s40264-016-0441-x. Full description at Econpapers || Download paper | 6 |
| 6 | 2016 | The Impact of Experiencing Adverse Drug Reactions on the Patientâs Quality of Life: A Retrospective Cross-Sectional Study in the Netherlands. (2016). Puijenbroek, Eugene ; Taxis, Katja ; Hunsel, Florence ; Rolfes, Lean. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:8:d:10.1007_s40264-016-0422-0. Full description at Econpapers || Download paper | 6 |
| 7 | 2017 | Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase®. (2017). Fransson, Jonas ; Noren, Niklas G ; Chandler, Rebecca E ; Juhlin, Kristina ; Edwards, Ralph I ; Caster, Ola. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:1:d:10.1007_s40264-016-0456-3. Full description at Econpapers || Download paper | 6 |
| 8 | 2016 | Social Media Mining for Toxicovigilance: Automatic Monitoring of Prescription Medication Abuse from Twitter. (2016). Gonzalez, Graciela ; Malone, Dan ; Smith, Karen ; Scotch, Matthew ; Ginn, Rachel ; Oconnor, Karen ; Sarker, Abeed . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:3:d:10.1007_s40264-015-0379-4. Full description at Econpapers || Download paper | 6 |
| 9 | 2016 | Appropriate Polypharmacy and Medicine Safety: When Many is not Too Many. (2016). Ryan, Cristin ; Hughes, Carmel M ; Cadogan, Cathal A. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:2:d:10.1007_s40264-015-0378-5. Full description at Econpapers || Download paper | 5 |
| 10 | 2019 | Patient Registries: An Underused Resource for Medicines Evaluation. (2019). PEter, ; Kurz, Xavier ; Bahri, Priya ; Zondag, Daniel Nogueras ; Castillon, Mireia ; Plueschke, Kelly ; Olmo, Carla Alonso ; McGettigan, Patricia. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:11:d:10.1007_s40264-019-00848-9. Full description at Econpapers || Download paper | 5 |
| 11 | 2016 | Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®. (2016). Olsson, Sten ; Pal, Shanthi N ; Hoekman, Jarno ; Alexander, ; Bruin, Marieke L ; Ampadu, Haggar H ; Sartori, Daniele. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:4:d:10.1007_s40264-015-0387-4. Full description at Econpapers || Download paper | 5 |
| 12 | 2016 | Adverse-Drug-Reaction-Related Hospitalisations in Developed and Developing Countries: A Review of Prevalence and Contributing Factors. (2016). Curtain, Colin M ; Angamo, Mulugeta Tarekegn ; Ke, LU ; Chalmers, Leanne. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:9:d:10.1007_s40264-016-0444-7. Full description at Econpapers || Download paper | 5 |
| 13 | 2016 | Sequence Symmetry Analysis as a Signal Detection Tool for Potential Heart Failure Adverse Events in an Administrative Claims Database. (2016). Pratt, Nicole L ; Roughead, Elizabeth E ; Ellett, Lisa Kalisch ; Wahab, Izyan A. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:4:d:10.1007_s40264-015-0391-8. Full description at Econpapers || Download paper | 4 |
| 14 | 2016 | A Survey of Adverse Event Reporting Practices Among US Healthcare Professionals. (2016). Felix, Thomas ; Brown, Carrie A ; Stergiopoulos, Stella ; Getz, Kenneth A ; Grampp, Gustavo . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:11:d:10.1007_s40264-016-0455-4. Full description at Econpapers || Download paper | 4 |
| 15 | 2019 | MADEx: A System for Detecting Medications, Adverse Drug Events, and Their Relations from Clinical Notes. (2019). Wu, Yonghui ; Hogan, William R ; Gong, Yan ; Bian, Jiang ; Yang, XI. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0761-0. Full description at Econpapers || Download paper | 4 |
| 16 | 2018 | Coronary Events After Dispensing of Ibuprofen: A Propensity Score-Matched Cohort Study Versus Paracetamol in the French Nationwide Claims Database Sample. (2018). Moore, Nicholas ; Blin, Patrick ; Droz, Cecile ; Lassalle, Regis ; Abouelfath, Abdelilah ; Duong, Mai. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:11:d:10.1007_s40264-018-0686-7. Full description at Econpapers || Download paper | 4 |
| 17 | 2019 | Adverse Drug Event Detection from Electronic Health Records Using Hierarchical Recurrent Neural Networks with Dual-Level Embedding. (2019). Kong, Xiangnan ; Rundensteiner, Elke A ; Sen, Cansu ; Kakar, Tabassum ; Qin, Xiao ; Wunnava, Susmitha. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0765-9. Full description at Econpapers || Download paper | 4 |
| 18 | 2016 | Patient Reporting of Adverse Drug Reactions: An International Survey of National Competent Authoritiesâ Views and Needs. (2016). Matos, Cristiano ; Hunsel, Florence ; Harmark, Linda. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:11:d:10.1007_s40264-016-0453-6. Full description at Econpapers || Download paper | 4 |
| 19 | 2017 | Factors Influencing the Use of a Mobile App for Reporting Adverse Drug Reactions and Receiving Safety Information: A Qualitative Study. (2017). , Peter ; PEter, ; Ruiz, Carmen Lasheras ; Houez, Franois ; Sutcliffe, Alastair ; Wong, Lisa ; Vries, Sieta T. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:5:d:10.1007_s40264-016-0494-x. Full description at Econpapers || Download paper | 4 |
| 20 | 2018 | What Future Healthcare Professionals Need to Know About Pharmacovigilance: Introduction of the WHO PV Core Curriculum for University Teaching with Focus on Clinical Aspects. (2018). Tanaka, Daisuke ; Schutte, Tim ; al Ramimmy, Hussain ; Parthasarathi, Gurumurthy ; Magro, Lara ; Koster, Andries S ; Rolfes, Lean ; van Eekeren, Rike ; Harmark, Linda ; van Puijenbroek, Eugene. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:11:d:10.1007_s40264-018-0681-z. Full description at Econpapers || Download The Patientâs Voice in Pharmacovigilance: Pragmatic Approaches to Building a Patient-Centric Drug Safety Organization. (2016). Smith, Meredith Y ; Benattia, Isma . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:9:d:10.1007_s40264-016-0426-9. Full description at Econpapers || Download paper | 4 |
| 22 | 2019 | Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR. (2019). Eemeren, Raphael ; Maskell, Simon ; Lewis, David J ; Tregunno, Phil ; PEter, ; Harmark, Linda ; Gama, Sara ; Bodin-Parssinen, Stephanie ; Vries, Sieta T ; Antoni, ; Pierce, Carrie E ; Dasgupta, Nabarun ; Newbould, Victoria ; Ptaszynska-Neophytou, Alicia. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:4:d:10.1007_s40264-019-00813-6. Full description at Econpapers || Download Social Media Listening for Routine Post-Marketing Safety Surveillance. (2016). Thomas, Michele ; Burstein, Phil J ; Powell, Gregory E ; Brownstein, John S ; Painter, Jeffery L ; Dasgupta, Nabarun ; Rodriguez, Harold W ; Pierce, Carrie E ; Bell, Heidi G ; Menius, Alan J ; Freifeld, Clark C ; Blowers, James ; Reblin, Tjark ; Seifert, Harry A. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:5:d:10.1007_s40264-015-0385-6. Full description at Econpapers || Download paper< | 4 |
| 24 | 2019 | Detecting Adverse Drug Events with Rapidly Trained Classification Models. (2019). Patterson, Olga V ; Duvall, Scott L ; Alba, Patrick R ; Peterson, Kelly S ; Chapman, Alec B. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0763-y. Full description at Econpapers || Download paper | 4 |
| 25 | 2017 | Patient Reporting in the EU: Analysis of EudraVigilance Data. (2017). Arlett, Peter ; Genov, Georgy ; Haerry, David ; Houez, Francois ; Slattery, Jim ; Candore, Gianmario ; Banovac, Marin . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:7:d:10.1007_s40264-017-0534-1. Full description at Econpapers || Download paper | 4 |
| 26 | 2018 | Sorting Through the Safety Data Haystack: Using Machine Learning to Identify Individual Case Safety Reports in Social-Digital Media. (2018). Fine, Jennifer ; Ramakrishnan, Cartic ; Nagarajan, Meenakshi ; Meireis, Shawman ; Dorrell, Darren ; Hudson, Zoe ; Perera, Sujan ; Comfort, Shaun. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:6:d:10.1007_s40264-018-0641-7. Full description at Econpapers || Download paper | 4 |
| 27 | 2018 | Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature. (2018). Pers, Yves-Marie ; Jorgensen, Christian ; Vernhet, Helene ; Roubille, Franois ; Chatre, Clotilde. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:10:d:10.1007_s40264-018-0689-4. Full description at Econpapers || Download paper | 4 |
| 28 | 2019 | Overview of the First Natural Language Processing Challenge for Extracting Medication, Indication, and Adverse Drug Events from Electronic Health Record Notes (MADE 1.0). (2019). Yu, Hong ; Liu, Weisong ; Jagannatha, Abhyuday. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0762-z. Full description at Econpapers || Download paper | 4 |
| 29 | 2017 | Effectiveness of Risk Evaluation and Mitigation Strategies (REMS) for Lenalidomide and Thalidomide: Patient Comprehension and Knowledge Retention. (2017). Zeldis, Jerome B ; Sheehan, Paul ; Houn, Florence ; Freeman, John ; Bwire, Robert ; Brandenburg, Nancy A. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:4:d:10.1007_s40264-016-0501-2. Full description at Econpapers || Download paper | 3 |
| 30 | 2018 | Time Series Disturbance Detection for Hypothesis-Free Signal Detection in Longitudinal Observational Databases. (2018). Bate, Andrew ; Hauben, Manfred ; Whalen, ED. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:6:d:10.1007_s40264-018-0640-8. Full description at Econpapers || Download paper | 3 |
| 31 | 2017 | Communication on Safety of Medicines in Europe: Current Practices and General Practitionersâ Awareness and Preferences. (2017). Andri, Adriana ; Ipi, Ivana ; Montero, Dolores ; Coleman, Anna Marie ; Baldelli, Ilaria ; Cupelli, Amelia ; PEter, ; Vries, Sieta T ; Denig, Petra ; Ahlqvist-Rastad, Jane ; Wennberg, Annika . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:8:d:10.1007_s40264-017-0535-0. Full description at Econpapers || Download paper | 3 |
| 32 | 2018 | From Big Data to Smart Data for Pharmacovigilance: The Role of Healthcare Databases and Other Emerging Sources. (2018). Bate, Andrew ; Sultana, Janet ; Trifiro, Gianluca. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:2:d:10.1007_s40264-017-0592-4. Full description at Econpapers || Download paper | 3 |
| 33 | 2017 | Adverse Drug Reaction-Related Hospitalizations in Elderly Australians: A Prospective Cross-Sectional Study in Two Tasmanian Hospitals. (2017). Bereznicki, Luke R ; Connolly, Michael ; Peterson, Gregory M ; Curtain, Colin ; Chalmers, Leanne ; Nair, Nibu Parameswaran . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:7:d:10.1007_s40264-017-0528-z. Full description at Econpapers || Download paper | 3 |
| 34 | 2016 | Post-Marketing BenefitâRisk Assessment of Rotavirus Vaccination in Japan: A Simulation and Modelling Analysis. (2016). Lieftucht, Alfons ; Sugiyama, Keiji ; Buyse, Hubert ; Holl, Katsiaryna ; Mckenna, Michael ; Ledent, Edouard . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:3:d:10.1007_s40264-015-0376-7. Full description at Econpapers || Download paper | 3 |
| 35 | 2019 | Artificial Intelligence and the Future of the Drug Safety Professional. (2019). Widdowson, Mark ; Abatemarco, Danielle ; Mockute, Ruta ; Tetarenko, Niki ; Assuncao, Bruno ; Mingle, Edward ; Cicirello, Salvatore ; Danysz, Karolina ; Desai, Sameen. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:4:d:10.1007_s40264-018-0746-z. Full description at Econpapers || Download paper | 3 |
| 36 | 2020 | Prevalence and Nature of Medication Errors and Medication-Related Harm Following Discharge from Hospital to Community Settings: A Systematic Review. (2020). Keers, Richard N ; Steinke, Douglas ; Alqenae, Fatema A. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:6:d:10.1007_s40264-020-00918-3. Full description at Econpapers || Download paper | 3 |
| 37 | 2016 | Performance of Stratified and Subgrouped Disproportionality Analyses in Spontaneous Databases. (2016). Arani, Ramin ; Wisniewski, Antoni ; Quarcoo, Naashika ; Juhlin, Kristina ; Candore, Gianmario ; Seabroke, Suzie ; Tregunno, Philip ; Painter, Jeffery ; Slattery, Jim ; Noren, Niklas G. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:4:d:10.1007_s40264-015-0388-3. Full description at Econpapers || Download paper | 3 |
| 38 | 2019 | Evaluation of Postmarketing Reports from Industry-Sponsored Programs in Drug Safety Surveillance. (2019). Dal, Gerald J ; Wu, Eileen ; Muoz, Monica A ; Kortepeter, Cindy M ; Kalra, Dipti ; Harinstein, Lisa. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:5:d:10.1007_s40264-018-0759-7. Full description at Econpapers || Download paper | 3 |
| 39 | 2020 | Follow-Up on the Use of Machine Learning in Clinical Quality Assurance: Can We Detect Adverse Event Under-Reporting in Oncology Trials?. (2020). Bowling, Rich ; Popko, Leszek ; Barmaz, Yves ; Rolo, Donato ; Koneswarakantha, Bjorn ; Menard, Timothe. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:3:d:10.1007_s40264-019-00894-3. Full description at Econpapers || Download paper | 3 |
| 40 | 2019 | Aim and Design of pREGnant, the Dutch Pregnancy Drug Register. (2019). Puijenbroek, Eugene ; Roeleveld, Nel ; Kant, Agnes ; Winkel, Bernke ; Vorstenbosch, Saskia. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0722-7. Full description at Econpapers || Download paper | 3 |
| 41 | 2017 | Frequency and Nature of Medication Errors and Adverse Drug Events in Mental Health Hospitals: a Systematic Review. (2017). Ashcroft, Darren M ; Keers, Richard N ; Alshehri, Ghadah H. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:10:d:10.1007_s40264-017-0557-7. Full description at Econpapers || Download paper | 3 |
| 42 | 2020 | Development and First Use of the Patientâs Qualitative Assessment of Treatment (PQAT) Questionnaire in Type 2 Diabetes Mellitus to Explore Individualised BenefitâHarm of Drugs Received During Clinical. (2020). de Climens, Aude Roborel ; Nguyen-Pascal, My-Lien ; Burrows, Kate ; Brun-Strang, Catherine ; Findley, Amy ; Reaney, Matthew ; Gater, Adam. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:2:d:10.1007_s40264-019-00877-4. Full description at Econpapers || Download | 3 |
| 43 | 2018 | Methods to Compare Adverse Events in Twitter to FAERS, Drug Information Databases, and Systematic Reviews: Proof of Concept with Adalimumab. (2018). Gonzalez-Hernandez, Graciela ; Oconnor, Karen ; Loke, Yoon ; Sarker, Abeed ; Golder, SU ; Smith, Karen. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:12:d:10.1007_s40264-018-0707-6. Full description at Econpapers || Download paper | 3 |
| 44 | 2018 | EudraVigilance Medicines Safety Database: Publicly Accessible Data for Research and Public Health Protection. (2018). Domergue, Francois ; Candore, Gianmario ; Kurz, Xavier ; Dogne, Jean-Michel ; Haren, Anja ; Slattery, Jim ; Brosch, Sabine ; Postigo, Rodrigo ; Arlett, Peter. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:7:d:10.1007_s40264-018-0647-1. Full description at Econpapers || Download paper | 3 |
| 45 | 2017 | Pharmaceutical BenefitâRisk Communication Tools: A Review of the Literature. (2017). Bouder, Frederic ; Way, Dominic ; Blazsin, Hortense ; Lofstedt, Ragnar. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:1:d:10.1007_s40264-016-0466-1. Full description at Econpapers || Download paper | 3 |
| 46 | 2018 | All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population. (2018). Sclar, David A ; Fairman, Kathleen A ; Peckham, Alyssa M. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:2:d:10.1007_s40264-017-0595-1. Full description at Econpapers || Download paper | 3 |
| 47 | 2019 | The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand?. (2019). Mugelli, Alessandro ; Clavenna, Antonio ; Corrao, Giovanni ; Moretti, Ugo ; Carnovale, Carla ; Mantovani, Lorenzo ; Lucenteforte, Ersilia ; Capuano, Annalisa ; Vannacci, Alfredo ; Leoni, Olivia ; Cantarutti, Anna ; Traversa, Giuseppe ; Leone, Roberto ; Beghi, Ettore ; Tettamanti, Mauro ; Lapi, Francesco ; Barone-Adesi, Francesco ; Sultana, Janet ; Kirchmayer, Ursula ; Gini, Rosa ; Rea, Federico ; Ingrasciotta, Ylenia ; Trifiro, Gianluca ; Rafaniello, Concita ; Franchi, Matteo ; Poluzzi, Elisabetta ; Ferrajolo, Carmen ; Naldi, Luigi ; Dellagiovanna, Mirosa. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:3:d:10.1007_s40264-018-07 | 3 |
| 48 | 2017 | Causality Assessment in Pharmacovigilance: Still a Challenge. (2017). Edwards, Ralph I. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:5:d:10.1007_s40264-017-0509-2. Full description at Econpapers || Download paper | 3 |
| 49 | 2017 | An Algorithm to Identify Generic Drugs in the FDA Adverse Event Reporting System. (2017). Singh, Sonal ; Segal, Jodi B ; Marimuthu, Sathiya Priya ; Iyer, Geetha . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:9:d:10.1007_s40264-017-0550-1. Full description at Econpapers || Download paper | 3 |
| 50 | 2016 | National ADR Monitoring System in China. (2016). Ye, Xiaofei ; Hou, Yongfang ; Li, Xinling ; Wu, Guizhi . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:11:d:10.1007_s40264-016-0446-5. Full description at Econpapers || Download paper | 3 |
50 most relevant documents in this series (papers most cited in the last two years)
| # | Year | Title | Cited |
|---|---|---|---|
| 1 | 2017 | Sensitivity of the UK Clinical Practice Research Datalink to Detect Neurodevelopmental Effects of Medicine Exposure in Utero: Comparative Analysis of an Antiepileptic Drug-Exposed Cohort. (2017). Richardson, J L ; Smithson, W H ; Clayton-Smith, J ; Wood, A ; Yates, L M ; Snowball, J ; Bromley, R ; McGrogan, A ; Baker, G A ; Charlton, R A ; McHugh, N. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:5:d:10.1007_s40264-017-0506-5. Full description at Econpapers || Download Spontaneous Reporting to Regulatory Authorities of Suspected Adverse Drug Reactions to COVID-19 Vaccines Over Time: The Effect of Publicity. (2022). Aronson, Jeffrey K ; Anton, Christopher ; Stevens, Richard J ; Ferner, Robin E. In: Drug Safety. RePEc:spr:drugsa:v:45:y:2022:i:2:d:10.1007_s40264-021-01138-z. Full description at Econpapers || Download paper | 2 |
| 3 | 2021 | Validating Intelligent Automation Systems in Pharmacovigilance: Insights from Good Manufacturing Practices. (2021). Taylor, Robert ; Leonard, Eileen ; Cherry, Mark ; Mishalov, Ellen ; Savage, Elizabeth ; Dobracki, Pawel ; Kjoersvik, Oeystein ; Huysentruyt, Kristof ; Abatemarco, Danielle ; Patel, Bhavin. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:3:d:10.1007_s40264-020-01030-2. Full description at Econpapers || Download paper | 2 |
| 4 | 2018 | EudraVigilance Medicines Safety Database: Publicly Accessible Data for Research and Public Health Protection. (2018). Domergue, Francois ; Candore, Gianmario ; Kurz, Xavier ; Dogne, Jean-Michel ; Haren, Anja ; Slattery, Jim ; Brosch, Sabine ; Postigo, Rodrigo ; Arlett, Peter. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:7:d:10.1007_s40264-018-0647-1. Full description at Econpapers || Download paper | 2 |
| 5 | 2019 | Aim and Design of pREGnant, the Dutch Pregnancy Drug Register. (2019). Puijenbroek, Eugene ; Roeleveld, Nel ; Kant, Agnes ; Winkel, Bernke ; Vorstenbosch, Saskia. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0722-7. Full description at Econpapers || Download paper | 2 |
| 6 | 2023 | Maternal and Early-Life Exposure to Antibiotics and the Risk of Autism and Attention-Deficit Hyperactivity Disorder in Childhood: a Swedish Population-Based Cohort Study. (2023). Odsbu, Ingvild ; Fornes, Romina ; Simin, Johanna ; Njotto, Lembris L ; Brusselaers, Nele ; Bruyndonckx, Robin ; Engstrand, Lars ; Callens, Steven ; Mussche, Isabelle. In: Drug Safety. RePEc:spr:drugsa:v:46:y:2023:i:5:d:10.1007_s40264-023-01297-1. Full description at Econpapers || Download pa | 2 |
Citing documents used to
compute impact factor: 6
| Year | Title | |
|---|---|---|
| 2024 | ||
| 2024 | ||
| 2024 | . Full description at Econpapers || Download paper | |
| 2024 | ||
| 2024 | ||
| 2024 |
Recent citations
Recent citations received in 2023
| Year | Citing document | |
|---|---|---|
| 2023 | ||
| 2023 | Real-World Monitoring of COVID-19 Vaccines: An Industry Expert View on the Successes, Challenges, and Future Opportunities. (2023). Jouquelet-Royer, Corinne ; Frise, Sarah ; Davis, Kourtney ; Bauchau, Vincent ; Wilkins, Jamie. In: Drug Safety. RePEc:spr:drugsa:v:46:y:2023:i:4:d:10.1007_s40264-023-01290-8. Full description at Econpapers || Download paper | |
| 2023 | Authorâs Reply to Kuss and Rathmannâs Comment on: âDrug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events. (2023). Alkabbani, Wajd ; Gamble, John-Michael. In: Drug Safety. RePEc:spr:drugsa:v:46:y:2023:i:5:d:10.1007_s40264-023-01293-5. Full description at Econpapers || Download paper | |
| 2023 | Authorsâ Reply to Juergen O Kirchnerâs Comment on âIncidence Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE Projectâ. (2023). , Miriam ; Weibel, Daniel ; Willame, Corinne. In: Drug Safety. RePEc:spr:drugsa:v:46:y:2023:i:8:d:10.1007_s40264-023-01311-6. Full description at Econpapers || Download paper | |
| 2023 | Comment on: âDeliberate Self-Poisoning: Real-Time Characterisation of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting Systemâ. (2023). Tuccori, Marco ; Convertino, Irma ; Ferraro, Sara ; Bonaso, Marco ; Valdiserra, Giulia ; Cappello, Emiliano. In: Drug Safety. RePEc:spr:drugsa:v:46:y:2023:i:9:d:10.1007_s40264-023-01330-3. Full description at Econpapers || Download paper |
Recent citations received in 2022
| Year | Citing document | |
|---|---|---|
| 2022 | Conundrum of Clinical QTc Monitoring. (2022). Malik, Marek. In: Drug Safety. RePEc:spr:drugsa:v:45:y:2022:i:10:d:10.1007_s40264-022-01229-5. Full description at Econpapers || Download paper | |
| 2022 | Authorsâ Response to Yoshihiro Noguchiâs Comment on: âA Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)â. (2022). Boyce, Richard D ; Tan, Malinda S ; Horn, John ; Gomez-Lumbreras, Ainhoa ; Villa-Zapata, Lorenzo ; Malone, Daniel C. In: Drug Safety. RePEc:spr:drugsa:v:45:y:2022:i:12:d:10.1007_s40264-022-01239-3. Full description at Econpapers || Download paper | |
| 2022 | Comment on: A Disproportionality Analysis of DrugâDrug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS). (2022). Noguchi, Yoshihiro. In: Drug Safety. RePEc:spr:drugsa:v:45:y:2022:i:12:d:10.1007_s40264-022-01240-w. Full description at Econpapers || Download paper | |
| 2022 | Authorsâ Reply to Noguchiâs comment on: âDrug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting. (2022). Alkabbani, Wajd ; Gamble, John-Michael. In: Drug Safety. RePEc:spr:drugsa:v:45:y:2022:i:7:d:10.1007_s40264-022-01192-1. Full description at Econpapers || Download paper |
Recent citations received in 2021
| Year | Citing document | |
|---|---|---|
| 2021 | . Full description at Econpapers || Download paper | |
| 2021 | . Full description at Econpapers || Download paper | |
| 2021 | The Effectiveness and Value of Written Medicine Information Across Asia and Africa: Systematic Review. (2021). Krska, Janet ; Corlett, Sarah A ; Nualdaisri, Pitchaya. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:12:d:10.1007_s40264-021-01114-7. Full description at Econpapers || Download paper | |
| 2021 | Authorsâ Reply to Robert P. Giugliano and Colleaguesâ Comment on: âDirect Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilanceâ. (2021). Poluzzi, Elisabetta ; Diemberger, Igor ; Fusaroli, Michele ; Raschi, Emanuel. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:4:d:10.1007_s40264-021-01054-2. Full description at Econpapers || Download paper | |
| 2021 | Authorsâ Reply to Michael Auerbachâs Comment on: âFrequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using. (2021). Numan, Syed ; Kaluza, Karolina ; Trumbo, Henry ; Goodnough, Lawrence T. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:5:d:10.1007_s40264-021-01059-x. Full description at Econpapers || Download paper | |
| 2021 | The Safety Profile of Upadacitinib in Patients with Rheumatoid Arthritis in Japan. (2021). Zhang, Ying ; Song, Yanna ; Harigai, Masayoshi ; Sasaki, Nobuhito ; Khan, Nasser ; Kameda, Hideto ; Tanaka, Yoshiya ; Yamaoka, Kunihiro ; Takeuchi, Tsutomu. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:6:d:10.1007_s40264-021-01067-x. Full description at Econpapers || Download paper | |
| 2021 | A Multi-modal Approach to Evaluate the Impact of Risk Evaluation and Mitigation Strategy (REMS) Programs. (2021). Manzo, Claudia ; Lacivita, Cynthia ; Toyserkani, Gita A ; Kesselheim, Aaron S ; Woloshin, Steven ; Chin, Kristyn ; Avorn, Jerry ; Feldman, William B ; Bykov, Katsiaryna ; Huybrechts, Krista F ; Mitra-Majumdar, Mayookha ; Gagne, Joshua J ; Sarpatwari, Ameet ; Dal, Gerald J ; Pinnow, Ellen ; Zhou, Esther H. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:7:d:10.1007_s40264-021-01070-2. Full description at Econpapers || Download Capturing Data in Rare Disease Registries to Support Regulatory Decision Making: A Survey Study Among Industry and Other Stakeholders. (2021). , Peter ; PEter, ; Hoes, Arno W ; McGettigan, Patricia ; Berg, Marijke H ; Vries, Sieta T ; Jonker, Carla J. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:8:d:10.1007_s40264-021-01081-z. Full description at Econpapers || Download paper | |
| 2021 | Authorsâ Reply to Braillon and Martinâs Comment on âProposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessme. (2021). , Sabine ; Dogne, Jean-Michel ; Inoubli, Adrien ; Morales, Daniel R ; Bahri, Priya. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:9:d:10.1007_s40264-021-01096-6. Full description at Econpapers || Download paper |
10 most frequent citing series